Now, however, there are data showing some sign of heart risk for every Cox-2 inhibitor ever approved in the U.S. Vioxx doubled the risk of heart attack and stroke in one cancer prevention study, and now the same is true for Celebrex.
FORBES: Pfizer's Heart Attack